Human Herpesvirus 6 (HHV-6) is a ubiquitous betaherpesvirus possessing specialized tropism for human astrocytes, microglia, oligodendrocytes, and CD4+ T-lymphocytes. In ME/CFS and post-acute infectious syndromes, recurrent clinical trials and neuroimaging confirm that smoldering HHV-6 reactivation correlates directly with severe neurocognitive deficits, sleep inversion, and autonomic collapse.

Historical Link Archive Citation

This monograph updates and synthesizes the international clinical conference proceedings originally published at aboutmecfs.org/Conf/HHV6PtII.aspx, cited across medical blogs, viral research clearinghouses, and patient networks.

HHV-6A vs. HHV-6B: Distinct Biological Entities

In 2012, the International Committee on Taxonomy of Viruses (ICTV) formally classified HHV-6A and HHV-6B as two distinct virus species based on genetic divergence, cellular tropism, and epidemiology (PMID: 24193951):

  • HHV-6B: Acquired by >90% of children before age two, classically presenting as roseola infantum (exanthem subitum). It establishes lifelong latency in salivary glands and monocytes.
  • HHV-6A: Exhibits far greater neurotropism and neuro-virulence. HHV-6A preferentially invades human neural progenitor cells, Purkinje cells of the cerebellum, and microglial networks. Unlike HHV-6B, HHV-6A has been repeatedly linked to severe adult neuro-inflammatory states and central nervous system pathology.

Neuro-PET Evidence of Microglial Activation

In a landmark study published in the Journal of Nuclear Medicine, Dr. Yasuhito Nakatomi and colleagues utilized positron emission tomography (PET) with the radioligand $^{11}\text{C-(R)-PK11195}$ (which binds specifically to translocator protein [TSPO] expressed by activated microglia and astrocytes).

The study demonstrated:

  1. Significant, widespread neuro-inflammation in the midbrain, thalamus, amygdala, hippocampus, and prefrontal cortex of ME/CFS patients compared to matched healthy controls.
  2. The intensity of microglial activation in the thalamus and midbrain correlated directly with the severity of cognitive fatigue, pain, and depression scores (PMID: 24665088).
  3. Reactivated HHV-6 in glial tissues is one of the principal biological drivers capable of maintaining this persistent sterile neuro-inflammatory state.

Dr. Bhupesh Prusty's Discovery: Mitochondrial Fragmentation

A monumental leap in understanding post-viral cellular exhaustion occurred when Dr. Bhupesh Prusty (University of Würzburg) uncovered how latent herpesviruses hijack host bioenergetics:

  • Disruption of Mitochondrial Dynamics: When HHV-6 infects human cells—even in an abortive or non-productive latent state—the viral genome induces rapid mitochondrial fission.
  • Fragmentation into Punctate Spheres: Under confocal fluorescence microscopy, healthy elongated mitochondrial tubular networks break apart into thousands of tiny, fragmented punctate spheroids within 48 hours of viral activation.
  • Metabolic Hibernation: Fragmented mitochondria cannot maintain transmembrane electrochemical potential ($\Delta\Psi_m$), shutting down ATP synthase and locking cells into a protective hypometabolic survival state (PMID: 31083256).

Chromosomally Integrated HHV-6 (ciHHV-6)

Approximately 0.8% to 1.0% of the world's population carries chromosomally integrated HHV-6 (ciHHV-6), where the complete viral genome is covalently integrated into the subtelomeric region of a human chromosome and transmitted through the germline in a Mendelian inheritance pattern:

Diagnostic Note for Clinicians

Individuals with ciHHV-6 possess one viral copy per every nucleated cell in their body. Whole-blood quantitative PCR will return staggeringly high viral loads (typically >1,000,000 copies/mL). Distinguishing true active lytic reactivation from ciHHV-6 requires hair follicle or fingernail testing, or testing for viral mRNA transcripts (such as U94 or late structural proteins).

Key Virology & Neuro-Immune Citations

  1. Prusty BK, Siegl C, Hauck CR. (2018). HHV-6 causes mitochondrial fragmentation in patient cells and activates dNTPase activity. ImmunoHorizons, 2(3): 83-94. PMID: 31083256
  2. Ablashi DV, Agut H, Alvarez-Lafuente R, Clark DA, Dewhurst S, DiLuca D, et al. (2014). Classification of HHV-6A and HHV-6B as distinct viruses. Archives of Virology, 159(5): 863-870. PMID: 24193951
  3. Nakatomi Y, Mizuno K, Ishii A, Wada Y, Tanaka M, Tazoe S, et al. (2014). Neuroinflammation in patients with chronic fatigue syndrome/myalgic encephalomyelitis: An 11C-(R)-PK11195 PET study. Journal of Nuclear Medicine, 55(6): 945-950. PMID: 24665088
  4. Kasahara F, Komaroff AL, Prusty BK. (2020). Human herpesvirus-6 and neuro-immune manifestations in post-viral illness. Frontiers in Cellular and Infection Microbiology, 10: 234. PMID: 32547990